XLO Xilio Therapeutics Inc
568
$1.25
$0.07
(5.93%)
| Watchers | 568 |
| 52-Wk Low | $0.49 |
| 52-Wk High | $3.25 |
| Market Cap | $46.14M |
| Volume | 289,226.00 |
| 52-Wk High | $3.25 |
| 52-Wk Low | $0.49 |
Xilio Therapeutics reports Q4 resultsSeekingAlpha.com: All News • about 1 month ago
Xilio Therapeutics reports Q4 results...
Share to Feed
On track with plans to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with microsatellite stable colorectal cancer (MSS...
Titoli in rialzo
Le azioni di Sunshine Biopharma (NASDAQ:SBFM) hanno fatto segnare +84,29% a 0,11 dollari durante la sessione regolare di luned .
Le azioni di Xilio Therapeutics (NASDAQ:XLO) sono...
Acciones al alza
Sunshine Biopharma (NASDAQ:SBFM) se anotaron un alza del 93,22% para establecerse en los 0,12 d lares durante la sesi n del regular del lunes.
Xilio Therapeutics (NASDAQ:XLO) ganaron...
Gagnants
Le titre Avalo Therapeutics (NASDAQ:AVTX) a mont vendredi de 289,05% 18,48 dollars lors de la session pre-market.
Le titre Xilio Therapeutics (NASDAQ:XLO) a grimp de 205,16% 1,95...
Titoli in rialzo
Le azioni di Avalo Therapeutics (NASDAQ:AVTX) sono cresciute del 289,05% a 18,48 dollari durante la sessione pre-market di venerd .
Il titolo Xilio Therapeutics (NASDAQ:XLO) salito...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Announces strategic portfolio reprioritization focused on rapid advancement of clinical-stage programs for XTX301, a tumor-activated, IL-12, and XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4...
Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilios Phase 1 tumor-activated IL-12...
-- Gilead Granted Exclusive License to Xilio's Tumor-Activated IL-12 Program, Including XTX301, a Clinical-Stage IL-12 Molecule with Potential to Treat a Broad Range of Cancers -- FOSTER CITY...